FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease - FDA.gov

[unable to retrieve full-text content]

1. FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease  FDA.gov
2. F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing  The New York Times
3. Gene editing could be a game changer for patients with sickle cell disease  CBS Mornings
4. A Sickle Cell Breakthrough Is Here. Now the Hard Part.  Bloomberg
5. The Download: inside the first CRISPR treatment, and smarter robots  MIT Technology Review

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease - FDA.gov
Read More